HU219476B - Eljárás valamely 2'-halo-metilidén-származékot és S-fázisú vagy M-fázisú specifikus daganatellenes szert tartalmazó gyógyszerkészítmények előállítására - Google Patents

Eljárás valamely 2'-halo-metilidén-származékot és S-fázisú vagy M-fázisú specifikus daganatellenes szert tartalmazó gyógyszerkészítmények előállítására Download PDF

Info

Publication number
HU219476B
HU219476B HU9402914A HU9402914A HU219476B HU 219476 B HU219476 B HU 219476B HU 9402914 A HU9402914 A HU 9402914A HU 9402914 A HU9402914 A HU 9402914A HU 219476 B HU219476 B HU 219476B
Authority
HU
Hungary
Prior art keywords
phase
formula
phase specific
halomethylidene
treatment
Prior art date
Application number
HU9402914A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9402914D0 (en
HUT71224A (en
Inventor
Sai P. Sunkara
Original Assignee
Merrell Dow Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc. filed Critical Merrell Dow Pharmaceuticals Inc.
Publication of HU9402914D0 publication Critical patent/HU9402914D0/hu
Publication of HUT71224A publication Critical patent/HUT71224A/hu
Publication of HU219476B publication Critical patent/HU219476B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
HU9402914A 1992-04-10 1993-03-15 Eljárás valamely 2'-halo-metilidén-származékot és S-fázisú vagy M-fázisú specifikus daganatellenes szert tartalmazó gyógyszerkészítmények előállítására HU219476B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86639992A 1992-04-10 1992-04-10
PCT/US1993/002490 WO1993020825A1 (en) 1992-04-10 1993-03-15 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent

Publications (3)

Publication Number Publication Date
HU9402914D0 HU9402914D0 (en) 1995-01-30
HUT71224A HUT71224A (en) 1995-11-28
HU219476B true HU219476B (hu) 2001-04-28

Family

ID=25347526

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402914A HU219476B (hu) 1992-04-10 1993-03-15 Eljárás valamely 2'-halo-metilidén-származékot és S-fázisú vagy M-fázisú specifikus daganatellenes szert tartalmazó gyógyszerkészítmények előállítására

Country Status (17)

Country Link
US (2) US20040102461A1 (de)
EP (1) EP0664708B1 (de)
JP (1) JP3713668B2 (de)
KR (1) KR100258668B1 (de)
AT (1) ATE170077T1 (de)
AU (1) AU667527B2 (de)
CA (1) CA2117891C (de)
DE (1) DE69320646T2 (de)
DK (1) DK0664708T3 (de)
ES (1) ES2123642T3 (de)
HU (1) HU219476B (de)
IL (1) IL105329A (de)
MX (1) MX9302038A (de)
NZ (1) NZ251211A (de)
TW (1) TW362971B (de)
WO (1) WO1993020825A1 (de)
ZA (1) ZA932455B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2768295A (en) * 1994-07-11 1996-02-09 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
EP0770621A4 (de) * 1994-07-12 1998-01-28 Yamasa Corp 2'-deoxy-2'(substituiertes oder unsubstituiertes methylidene)-4-thionukleosid
ES2435722T3 (es) 1997-09-04 2013-12-23 Demerx, Inc. Noribogaína en el tratamiento del dolor y de la adicción a drogas
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US6544962B1 (en) 2000-11-02 2003-04-08 Matrix Pharmaceutical, Inc. Methods for treating cellular proliferative disorders
WO2003068162A2 (en) * 2002-02-14 2003-08-21 Pharmasset Ltd. Modified fluorinated nucleoside analogues
WO2004042081A1 (de) * 2002-11-04 2004-05-21 Charité-Universitätsme Dizin Berlin Spezifische haplotypen des mdr1-gens und deren anwendung in der diagnose und therapie
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
WO2012012764A1 (en) 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
EP2481740B1 (de) 2011-01-26 2015-11-04 DemeRx, Inc. Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA2855994A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
SG10201610936RA (en) 2011-12-22 2017-02-27 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
CA2989550C (en) 2014-06-18 2023-08-08 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Also Published As

Publication number Publication date
EP0664708B1 (de) 1998-08-26
EP0664708A1 (de) 1995-08-02
KR950700749A (ko) 1995-02-20
CA2117891A1 (en) 1993-10-28
HU9402914D0 (en) 1995-01-30
KR100258668B1 (ko) 2000-07-01
AU667527B2 (en) 1996-03-28
ES2123642T3 (es) 1999-01-16
MX9302038A (es) 1993-10-01
US20040102461A1 (en) 2004-05-27
CA2117891C (en) 1998-07-07
HUT71224A (en) 1995-11-28
NZ251211A (en) 1997-05-26
DE69320646D1 (de) 1998-10-01
DK0664708T3 (da) 1998-11-02
IL105329A (en) 1998-06-15
JPH07505653A (ja) 1995-06-22
US20050032738A1 (en) 2005-02-10
TW362971B (en) 1999-07-01
ZA932455B (en) 1993-10-20
WO1993020825A1 (en) 1993-10-28
AU3813193A (en) 1993-11-18
ATE170077T1 (de) 1998-09-15
DE69320646T2 (de) 1999-01-14
IL105329A0 (en) 1993-08-18
JP3713668B2 (ja) 2005-11-09
EP0664708A4 (de) 1995-04-24

Similar Documents

Publication Publication Date Title
HU219476B (hu) Eljárás valamely 2'-halo-metilidén-származékot és S-fázisú vagy M-fázisú specifikus daganatellenes szert tartalmazó gyógyszerkészítmények előállítására
JP4049477B2 (ja) 副作用軽減剤
JP5005532B2 (ja) １０−プロパルギル−１０−デアザアミノプテリンを用いるｔ細胞リンパ腫の治療
UA79764C2 (en) 3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
US5654287A (en) Method of treating cancer by conjunctive therapy with N,N1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
JP5730854B2 (ja) デシタビンとシチジンデアミナーゼ阻害剤との組合せ、およびがんの治療におけるその使用
JP5684787B2 (ja) シチジンベースの抗新生物薬とシチジンデアミナーゼ阻害薬との組合せ、および癌の治療におけるその使用
US8383605B2 (en) Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
KR101401220B1 (ko) 방사선 치료 증강제
RU2007104176A (ru) Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов
ES2671730T3 (es) Terapia de combinación para el cáncer de ovario
JP2012522840A (ja) 癌を治療するための（２’−デオキシ−リボフラノシル）−１，３，４，７−テトラヒドロ−（１，３）ジアゼピン−２−オン誘導体
KR100195423B1 (ko) N,n'-비스(3-(에틸아미노)프로필)-1,7-헵탄디아민 및 세포독성제를 함유하는 암치료용 제약조성물
US8586561B2 (en) Anti-tumor agent comprising cytidine derivative and carboplatin
RU2012102404A (ru) Индолил-замещенные пиразино-хинолины и их применение для лечения рака
CN112704738A (zh) 使用克来夫定和替比夫定治疗癌症和其它病症或疾病状态的方法
WO2015044365A1 (en) Dinucleoside derivatives as prodrugs of gemcitabine and cytarabine

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees